Page last updated: 2024-11-05

trihexyphenidyl and Apraxias

trihexyphenidyl has been researched along with Apraxias in 2 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Apraxias: A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krack, P1
Marion, MH1
Klostermann, W1
Vieregge, P1
Kömpf, D1

Other Studies

2 other studies available for trihexyphenidyl and Apraxias

ArticleYear
"Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patients.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Apraxias; Blepharospasm; Botulinum Toxins; Dose-Response Relationshi

1994
Apraxia of eyelid opening after bilateral stereotaxic subthalamotomy.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1997, Volume: 17, Issue:2

    Topics: Adult; Antiparkinson Agents; Apraxias; Blinking; Dystonia Musculorum Deformans; Eyelid Diseases; Hum

1997